FDA: Anonymity Assured In Pending Cosmetic Manufacturing Practices Survey
This article was originally published in The Rose Sheet
Executive Summary
The agency clarified in an email to Rose Sheet that an independent contractor would be tasked with conducting a planned survey on current cosmetic manufacturing practices, which remains subject to public comment and OMB approval. Respondents could count on their responses to be anonymous, FDA says.